Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
IMC002 / Immuneoncia Therap
NCT04306224: A Study of IMC-002 in Subjects With Metastatic or Locally Advanced Solid Tumors and Relapsed or Refractory Lymphomas	Completed	1	12	US, RoW	IMC-002	ImmuneOncia Therapeutics Inc.	Solid Tumor, Lymphoma	10/22	10/22
NCT05276310: A Study of IMC-002 in Patients with Advanced Cancer Failed to Standard Therapy	Recruiting	1	49	RoW	IMC-002	ImmuneOncia Therapeutics Inc.	Advanced Cancer	06/25	12/26